wada 2025 prohibited list bpc-157 WADA's 2026 is now in force WADA's 2026 Prohibited List now
Description
Introduction BPC-157 PEN 20 mg from the Endogenic line is one of the most frequently cited regeneration peptides, supplied in a pre-dissolved PEN-type applicator a factory-prepared solution that eliminates the reconstitution step
The remaining 15 firms responded to the document request and received warning letters based on their (inadequate) responses
Versatile Study Frameworks: AOD9604 Peptide is suitable for a variety of in vitro and in vivo models, ranging from metabolic syndrome studies to regenerative medicine research
Recht: Kein zugelassenes Arzneimittel in der DACH-Region
